09:35 AM EDT, 06/26/2024 (MT Newswires) -- Oramed Pharmaceuticals ( ORMP ) said Wednesday that its board approved a share-buyback program of up to $20 million.
The program is effective over a 12-month period and will be funded with existing cash, the company said.
Price: 2.41, Change: +0.17, Percent Change: +7.59